Core Viewpoint - A class action lawsuit has been filed against Avantor, Inc. on behalf of shareholders who purchased common stock during the specified class period from March 5, 2024, to October 28, 2025 [1] Company Summary - Avantor, Inc. is a provider of scientific products and services catering to various industries [1]

Core Insights - Avantor, Inc. is a global provider of mission-critical products and services in the life sciences and advanced technologies sectors, competing with major players like Thermo Fisher Scientific and Merck KGaA [1] Financial Performance - Avantor's third-quarter 2025 financial results were disappointing, with adjusted earnings per share (EPS) decreasing by 15.4% year-over-year to $0.22, missing the Zacks Consensus Estimate by 4.4% [3][6] - The company reported a GAAP loss per share of $1.04, compared to an EPS of $0.08 in the same quarter last year [3] - Revenues for the quarter totaled $1.62 billion, representing a 5.3% decline from the previous year and falling short of the Zacks Consensus Estimate by 1.6% [4][6] - Organic sales declined by 4.7%, with core segments also posting declines [4][6] Stock Performance and Guidance - Following the disappointing financial performance, Avantor's stock price plunged by 23.2% [5][6] - The company revised its full-year 2025 guidance, projecting EPS to be between $0.88 and $0.92, with organic sales expected to decrease by up to 3.5% [5] - JPMorgan Chase and Co. adjusted the price target for Avantor from $17.00 to $14.00 [5] Insider Activity - On October 30, 2025, SUMME GREGORY L, a director at Avantor, purchased 100,000 shares at $11.25 per share, increasing his total holdings to 300,000 shares [2]

LOS ANGELES--(BUSINESS WIRE)--The Law Offices of Frank R. Cruz announces an investigation of Avantor, Inc. ("Avantor†or the "Company†) (NYSE: AVTR) on behalf of investors concerning the Company's possible violations of federal securities laws. IF YOU ARE AN INVESTOR WHO LOST MONEY ON AVANTOR, INC. (AVTR), CLICK HERE TO INQUIRE ABOUT POTENTIALLY PURSUING A CLAIM TO RECOVER YOUR LOSS. What Is The Investigation About? On April 25, 2025, Avantor released its first quarter 2025 financial results, m. ...

NEW YORK, Oct. 31, 2025 (GLOBE NEWSWIRE) -- Gainey McKenna & Egleston announces that a securities class action lawsuit has been filed in the United States District Court for the Eastern District of Pennsylvania on behalf of all persons or entities who purchased or otherwise acquired Avantor, Inc. (“Avantor” or the “Company”) (NYSE: AVTR) securities between March 5, 2024 and October 28, 2025, inclusive (the “Class Period”). The Complaint alleges that Defendants misled investors by falsely touting the Company ...

Core Viewpoint - A class action lawsuit has been filed against Avantor, Inc. for alleged violations of federal securities laws during the specified class period [1][2]. Group 1: Lawsuit Details - The lawsuit seeks to recover damages for all individuals and entities that purchased Avantor securities between March 5, 2024, and October 28, 2025 [2]. - The Complaint alleges that Defendants made materially false and misleading statements and failed to disclose adverse facts about Avantor's business and operations [3]. - Specific allegations include that Avantor's competitive positioning was weaker than represented, the company faced negative impacts from increased competition, and the Defendants' statements lacked a reasonable basis [3]. Group 2: Next Steps for Investors - Investors who suffered losses in Avantor have until December 29, 2025, to request to be appointed as lead plaintiff in the case [4]. - Participation in any recovery does not require serving as lead plaintiff [4]. Group 3: Legal Representation - Bronstein, Gewirtz & Grossman, LLC operates on a contingency fee basis, meaning they will only seek reimbursement for expenses and fees if successful [5]. - The firm has a history of recovering hundreds of millions of dollars for investors in securities fraud class actions [6].

NEW YORK, Oct. 31, 2025 (GLOBE NEWSWIRE) -- Bernstein Liebhard LLP announces that a shareholder has filed a securities class action lawsuit on behalf of investors (the “Class”) who purchased or acquired the common stock of Avantor, Inc. (“Avantor” or the “Company”) (NYSE: AVTR) between March 5, 2024 and October 28, 2025, inclusive. For more information, submit a form at Avantor, Inc. Shareholder Class Action Lawsuit, email Investor Relations Manager Peter Allocco at pallocco@bernlieb.com, or call us at (212 ...

Core Viewpoint - The Avantor class action lawsuit alleges that the company and its executives misrepresented the competitive positioning and financial health of Avantor, leading to significant stock price declines following disappointing financial results [1][3][4][5][6]. Group 1: Allegations and Financial Performance - The lawsuit claims that Avantor failed to disclose its weaker competitive positioning and the negative impact of increased competition during the class period [3]. - On April 25, 2025, Avantor reported weak first-quarter results, with the CFO admitting to the impact of increased competition, resulting in a stock price drop of over 16% [4]. - On August 1, 2025, the company reported disappointing second-quarter results and reduced its full-year guidance, leading to a further stock price decline of more than 15% [5]. - On October 29, 2025, Avantor announced weak third-quarter results, including a 5% decrease in organic revenue growth, causing the stock price to fall by over 23% [6]. Group 2: Legal Process and Representation - The Private Securities Litigation Reform Act of 1995 allows any investor who purchased Avantor common stock during the class period to seek appointment as lead plaintiff in the lawsuit [7]. - The lead plaintiff represents the interests of all class members and can select a law firm of their choice for litigation [7]. Group 3: Law Firm Background - Robbins Geller Rudman & Dowd LLP is a leading law firm specializing in securities fraud and shareholder litigation, having recovered over $2.5 billion for investors in 2024 alone [8]. - The firm has been ranked 1 in securing monetary relief for investors in securities class action cases for four out of the last five years [8].

Core Viewpoint - The Avantor class action lawsuit alleges that the company and its executives misrepresented the competitive positioning and financial health of Avantor, leading to significant stock price declines following disappointing financial results [3][4][5][6]. Group 1: Lawsuit Details - The lawsuit is titled "Building Trades Pension Fund of Western Pennsylvania v. Avantor, Inc." and is filed in the Eastern District of Pennsylvania [1]. - It seeks to represent purchasers of Avantor common stock and claims violations of the Securities Exchange Act of 1934 [1]. - The lead plaintiff motions must be filed by December 29, 2025 [2]. Group 2: Allegations of Misrepresentation - The lawsuit alleges that Avantor's competitive positioning was weaker than publicly represented, and the company faced negative impacts from increased competition [3]. - On April 25, 2025, Avantor reported weak first-quarter results, leading to a stock price drop of over 16% [4]. - On August 1, 2025, the company reported disappointing second-quarter results and reduced its full-year guidance, causing a further stock price decline of over 15% [5]. - On October 29, 2025, Avantor announced weak third-quarter results, including a 5% decrease in organic revenue growth, resulting in a stock price drop of over 23% [6]. Group 3: Company Background - Avantor provides mission-critical products and services to various sectors, including biopharma, healthcare, education, and advanced technologies [3].

Core Points - A class action lawsuit has been filed against Avantor, Inc. on behalf of investors who purchased its common stock between March 5, 2024, and October 28, 2025 [1] - The lawsuit alleges that Avantor misled investors regarding its competitive positioning and the negative impacts of increased competition on its business [2] - Avantor reported weak Q3 2025 financial results, including a -5% organic revenue growth and a net loss of $712 million, primarily due to a non-cash goodwill impairment charge of $785 million attributed to competitive pressures [3] Allegations - The complaint states that Avantor's competitive positioning was weaker than publicly represented [2] - It claims that the company was experiencing negative effects from increased competition, which were not disclosed to investors [2] - The representations made by the defendants about the company's business and prospects were materially false and misleading [2] Financial Impact - On October 29, 2025, Avantor's stock price fell by $3.50 per share, or over 23%, closing at $11.58 per share after the announcement of poor financial results [3] - The reported net loss of $712 million was significantly impacted by a goodwill impairment charge of $785 million, indicating severe competitive pressures affecting margins [3]

Core Viewpoint - Faruqi & Faruqi, LLP is investigating potential claims against Avantor, Inc. due to allegations of misleading statements regarding the company's competitive position and performance, which have led to significant investor losses [2][4]. Group 1: Allegations and Misleading Statements - The complaint alleges that Avantor and its executives violated federal securities laws by making false and misleading statements about the company's competitive positioning and failing to disclose the negative impacts of increased competition [4]. - During an earnings call on July 26, 2024, the then CEO Michael Stubblefield assured investors of Avantor's strong competitive position, despite evidence suggesting otherwise [5]. - The company downplayed the effects of increased competition, claiming competitive advantages that were later proven to be overstated [5]. Group 2: Financial Performance and Stock Impact - On April 25, 2025, Avantor reported disappointing Q1 2025 results, cutting its guidance and attributing weak performance to increased competitive intensity, resulting in a stock price drop of over 16.5% [6]. - The company further reported a year-over-year decrease in net sales on August 1, 2025, and projected organic revenue growth of -2% to 0%, leading to another stock decline of more than 15% [7][8]. - In Q3 2025, Avantor reported a net loss of $712 million, primarily due to a non-cash goodwill impairment charge of $785 million, which was attributed to competitive pressures, causing the stock to drop over 23% [9][10].